Niagen Bioscience (NAGE) Other Operating Expenses (2010 - 2026)

Niagen Bioscience (NAGE) has 17 years of Other Operating Expenses data on file, last reported at $4.8 million in Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $4.8 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $30.2 million (up 32.83% YoY), and the FY2025 annual result was $33.5 million, up 13.76% from the prior year.
• Other Operating Expenses slipped to $4.8 million in Q1 2026 per NAGE's latest filing, from $8.4 million in the prior quarter.
• Over five years, Other Operating Expenses peaked at $8.8 million in Q3 2025 and troughed at $4.8 million in Q1 2026.
• A 5-year average of $7.2 million and a median of $7.0 million in 2024 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2022 and 2024: Other Operating Expenses dropped 28.4% in 2022, then jumped 33.68% in 2024.
• A 5-year view of Other Operating Expenses shows it stood at $6.2 million in 2022, then climbed by 5.38% to $6.5 million in 2023, then surged by 33.68% to $8.7 million in 2024, then decreased by 3.27% to $8.4 million in 2025, then sank by 43.26% to $4.8 million in 2026.
• Business Quant data shows NAGE's Other Operating Expenses at $4.8 million in Q1 2026, $8.4 million in Q4 2025, and $8.8 million in Q3 2025.